Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies

Affiliations

• ¹ Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
• ² College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA.
• ³ Division of Hematology and Oncology, Department of Pediatrics, Moores Cancer Center, University of California San Diego, CA, USA.
• ⁴ Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA.
• ⁵ Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.